Effect of Bioptron on Primary Dysmenorrhea
ConditionDysmenorrhea
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-24
SponsorCairo University
About this trial
This study will be conducted to determine the effect of bioptron on PD through the assessment of serum progesterone level, and pain level measured by pressure algometry in addition to evaluation of the symptoms of PD and its effect on girl's quality of life through valid and reliable questionnaires which will be of valuable benefits in the women's health fields.
Eligibility criteria
Qualifiers
Self-reported history of PD, at least moderate pain due to menstrual cramps (>4 on VAS)
They have moderate symptoms of PD on the WaILDD questionnaire, (5-12) Teheran et al., 2018).
Their ages will be ranged from 18-24 years old.
Their BMI will be less than 30 kg/m².
Disqualifiers
Musculoskeletal or neurological disorders.
Patients with a history of phototherapy allergy.
Professional athletes (Jill et al., 2012).
Secondary dysmenorrhea pathology such as (endometriosis, fibroids, adenomyosis, and pelvic inflammatory disease)
Trial design
Treatments tested in this trial
- Bioptron Pro 1 Class II
- Vitamin D
Treatment groups
56 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov